Viewing StudyNCT05777278



Ignite Creation Date: 2024-05-06 @ 6:45 PM
Last Modification Date: 2024-10-26 @ 2:54 PM
Study NCT ID: NCT05777278
Status: RECRUITING
Last Update Posted: 2023-10-10
First Post: 2023-02-21

Brief Title: Savolitinib Plus Docetaxel as 2L in EGFRALKROS1MET ex14m-wildtype NSCLC With MET Overexpression
Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Organization: The First Affiliated Hospital of Guangzhou Medical University

Organization Data

Organization: The First Affiliated Hospital of Guangzhou Medical University
Class: OTHER
Study ID: FirstMET ESR-22-21748
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: The First Affiliated Hospital of Guangzhou Medical University
Lead Sponsor Class: OTHER
Responsible Party: Jianxing He
Responsible Party Title: Professor
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation: The First Affiliated Hospital of Guangzhou Medical University
Old Name: None
Old Organization: None

Collaborators